Accessibility Statement
Robugen GmbH & Co. KG is committed to making its website accessible in accordance with the German Accessibility Strengthening Act (Barrierefreiheitsstärkungsgesetz – BFSG) and the corresponding ordinance (BFSGV).
This accessibility statement applies to:
https://www.antihydral.de
Description of the Service
This website is a product landing page for a pharmacy-only medicinal product. It provides information about indications, mode of action, and other product-related content for patients and healthcare professionals.
Compliance Status
This website is partially compliant with the requirements of the harmonized standard EN 301 549 and the Web Content Accessibility Guidelines (WCAG) 2.1, Conformance Level AA.
Non-Accessible Content
The content listed below is not yet fully accessible for the following reasons:
- Some images are missing meaningful alternative text
- Certain decorative graphics are not correctly marked as decorative
- Color contrasts do not consistently meet minimum accessibility requirements
- The semantic structure (e.g., heading hierarchy) is not fully consistent across all pages
- Some interactive elements are not fully operable via keyboard navigation
- Keyboard focus indicators are partially insufficiently visible
- Some form fields are not correctly labeled
Robugen GmbH & Co. KG continuously works to identify and remove these accessibility barriers.
Preparation of This Statement
This statement was created on April 28, 2026.
The website was evaluated through self-assessment.
Feedback and Contact Information
Have you noticed any accessibility issues when using our website content?
If so, please contact us:
Robugen GmbH & Co. KG
Alleenstraße 22–24
Email: info@robugen.de
Phone: +49 711 136300
We will make every effort to respond to your inquiry within the legally required timeframe.
Dispute Resolution Procedure
If you do not receive a satisfactory response from us within a reasonable period of time, you may contact the arbitration body:
Arbitration Service under the German Equal Opportunities for Persons with Disabilities Act
Office of the Federal Government Commissioner for Matters Relating to Persons with Disabilities
Mauerstraße 53
10117 Berlin
Germany
Email: info@schlichtungsstelle-bgg.de
Web: https://www.schlichtungsstelle-bgg.de
Market Surveillance Authority
Responsible authority:
Market Surveillance Authority of the Federal States for the Accessibility of Products and Services (MLBF)
Carl-Miller-Straße 6
39112 Magdeburg
Germany
Email: MLBF@ms.sachsen-anhalt.de
Phone: +49 391 567 6970



